Effect of Shool Prashman Dashemani Choorn im Udavartini Yoni Vyapad i.e. Dysmenorrhea or painful menstruation.

Phase 4

Not yet recruiting

• Conditions: Dysmenorrhea, unspecified,

• Registration Number: CTRI/2019/02/017707
• Lead Sponsor: IPGTRA

Brief Summary

This study is randomized comparative clinical trial to compare the efficacy of Shool Prashman Dashemani Choorn 5gm with Erand Bhrusht Haritaki and Shunthi  Choorn in the management of the Udavartini Yoni Vyapad (Dysmenorrhea). Total 30 patients will be enrolled in the present study. selected patients will be divided into two groups on the basis of the computer generated randomization. In this study Shool Prashman Choorn 5mg with anupaan of cow’s ghee twice a day followed by luke warm water will be given in group A and Erand Bhrusht Haritaki and Shunthi Churn 5gm followed by luke warm water will be given to the patients in group B for 2 months. Post trial follow up for 1 month will be carried out.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-02-16
• Study Start: 2019-02-19

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Both married and unmarried subjects chief complaint of cramping pain 1day or more prior to the onset of menstruation and during the menstruation along with other symptoms, pain along with scanty or irregular menses, hypothyroidism, PCOS.

Exclusion Criteria

age less that 18 or more than 30 years, not willing to participate in the study, severe anemia, known case of acid peptic disease, peptic ulcer disease or gastro esophageal reflux, bleeding disorders, uncontrolled diabetes and hypertension, other severe systemic illnesses.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decrease in Pain score and menstrual distress symptoms with regularity of menses	Every month at the onset of menstruation, for two consecutive month followed by one month follow up post trial

Secondary Outcome Measures

Name	Time	Method
Safety of the drug, improvement in the secondary causes of the dysmenorrhea.	2 months

Trial Locations

Locations (1)

Room no 7 OPD PTSR, IPGTRA HOSPITAL; 🇮🇳 Jamnagar, GUJARAT, India

Room no 7 OPD PTSR, IPGTRA HOSPITAL

🇮🇳Jamnagar, GUJARAT, India

Arun Gupta

Principal investigator

9596306387

gupta.arun9@gmail.com